11,577
Total Claims
$1.1M
Drug Cost
1,076
Beneficiaries
$1,009
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-5%
Cost per patient vs peers
$1,009 vs $1,068 avg
+36%
Brand preference vs peers
12.2% vs 9.0% avg
Brand vs Generic
88% generic
Brand: 1,403 claims · $893K
Generic: 10,102 claims · $191K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 116 | $115K |
| Apixaban | 76 | $96K |
| Dulaglutide | 63 | $94K |
| Semaglutide | 50 | $92K |
| Semaglutide | 56 | $82K |
| Rivaroxaban | 60 | $75K |
| Budesonide/Formoterol Fumarate | 121 | $69K |
| Dapagliflozin Propanediol | 28 | $44K |
| Insulin Glargine,hum.Rec.Anlog | 45 | $26K |
| Sitagliptin Phosphate | 17 | $26K |
| Insulin Detemir | 14 | $16K |
| Sitagliptin Phos/Metformin Hcl | 15 | $12K |
| Levothyroxine Sodium | 670 | $11K |
| Fluticasone Propion/Salmeterol | 20 | $8,797 |
| Atorvastatin Calcium | 767 | $8,761 |
Prescribing Profile
Patient Profile
73
Avg Age
39%
Female
0.96
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About